{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:34:04Z","timestamp":1790084044127,"version":"4.0.1"},"reference-count":175,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jogc.2023.05.012","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T17:18:07Z","timestamp":1700068687000},"page":"102144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Guideline No. 443b: Opioid Use Throughout Women\u2019s Lifespan: Opioid Use in Pregnancy and Breastfeeding"],"prefix":"10.1016","volume":"45","author":[{"given":"Suzanne","family":"Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria M.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Tanguay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelynn L.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2023.05.012_bib1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.annepidem.2013.05.017","article-title":"Increasing pregnancy-related use of prescribed opioid analgesics","volume":"23","author":"Epstein","year":"2013","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jogc.2023.05.012_bib2","first-page":"612","article-title":"Canada's hidden opioid crisis: the health care system's inability to manage high-dose opioid patients: Fallout from the 2017 Canadian opioid guidelines","volume":"65","author":"Clarke","year":"2019","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jogc.2023.05.012_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/AOG.0000000000004657","article-title":"What Obstetrician-Gynecologists Should Know About Substance Use Disorders in the Perinatal Period","volume":"139","author":"Smid","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jogc.2020.09.017","article-title":"Opioid and Cannabis Use During Pregnancy and Breastfeeding in Relation to Sociodemographics and Mental Health Status: A Descriptive Study","volume":"43","author":"Grywacheski","year":"2021","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2023.05.012_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.8256","article-title":"Association of Maternal Opioid Use in Pregnancy With Adverse Perinatal Outcomes in Ontario, Canada, From 2012 to 2018","volume":"3","author":"Corsi","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jogc.2023.05.012_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.37388","article-title":"Prevalence of Prenatal Opioid Exposure in Ontario, Canada, 2014-2019","volume":"4","author":"Camden","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jogc.2023.05.012_bib7","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/ALN.0000000000000172","article-title":"Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States","volume":"120","author":"Bateman","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jogc.2023.05.012_bib8","doi-asserted-by":"crossref","first-page":"897","DOI":"10.15585\/mmwr.mm6928a1","article-title":"Vital Signs: Prescription Opioid Pain Reliever Use During Pregnancy - 34 U.S. Jurisdictions, 2019","volume":"69","author":"Ko","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jogc.2023.05.012_bib9","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/AOG.0000000000002229","article-title":"711 Summary: Opioid Use and Opioid Use Disorder in Pregnancy","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib10","series-title":"Diagnostic and Statistical Manual of\u00a0Mental Disorders: Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.jogc.2023.05.012_bib11","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/ALN.0000000000000472","article-title":"Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes","volume":"121","author":"Maeda","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jogc.2023.05.012_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1360-0443.1994.tb00896.x","article-title":"Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors","volume":"89","author":"Griffiths","year":"1994","journal-title":"Addiction"},{"key":"10.1016\/j.jogc.2023.05.012_bib13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jogc.2022.01.012","article-title":"Guideline No. 440a: Opioid use throughout the Women\u2019s Lifespan: Fertility, Contraception, Chronic Pain, and Menopause","volume":"44","author":"Turner","year":"2022","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2023.05.012_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/bs.vh.2019.07.001","article-title":"Opioids and reproduction","volume":"111","author":"Seeber","year":"2019","journal-title":"Vitam Horm"},{"key":"10.1016\/j.jogc.2023.05.012_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/GRF.0000000000000288","article-title":"Peripartum Anesthetic Management of the Opioid-tolerant or Buprenorphine\/Suboxone-dependent Patient","volume":"60","author":"Pan","year":"2017","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.5708","article-title":"Association of Gestational Opioid Exposure and Risk of Major and Minor Congenital Malformations","volume":"4","author":"Wen","year":"2021","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.jogc.2023.05.012_bib17","doi-asserted-by":"crossref","first-page":"E152","DOI":"10.1503\/cmaj.211215","article-title":"Prescribed opioid analgesics in early pregnancy and the risk of congenital anomalies: a population-based cohort study","volume":"194","author":"Bowie","year":"2022","journal-title":"CMAJ"},{"key":"10.1016\/j.jogc.2023.05.012_bib18","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-4131","article-title":"Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review","volume":"139","author":"Lind","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.jogc.2023.05.012_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10826084.2021.1958851","article-title":"Neonatal Outcomes of Infants Born to Pregnant Women With Substance Use Disorders: A Multilevel Analysis of Linked Data","volume":"57","author":"Oni","year":"2022","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.jogc.2023.05.012_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002980","article-title":"Maternal prescribed opioid\u00a0analgesic use during pregnancy and associations with adverse birth\u00a0outcomes: A population-based study","volume":"16","author":"Sujan","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.jogc.2023.05.012_bib21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/EDE.0000000000001328","article-title":"Prenatal Opioid Analgesics and the Risk of Adverse Birth Outcomes","volume":"32","author":"Brogly","year":"2021","journal-title":"Epidemiology"},{"key":"10.1016\/j.jogc.2023.05.012_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/ppe.12805","article-title":"Infants' prenatal exposure to opioids and the association with birth outcomes: A systematic review and meta-analysis","volume":"36","author":"Graeve","year":"2022","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/j.jogc.2023.05.012_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.6405","article-title":"Prenatal Risk Factors and Perinatal and Postnatal Outcomes Associated With Maternal Opioid Exposure in an Urban, Low-Income, Multiethnic US Population","volume":"2","author":"Azuine","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jogc.2023.05.012_bib24","first-page":"e441","article-title":"Narcotic-exposed neonates in a First Nations population in northwestern Ontario: incidence and implications","volume":"57","author":"Kelly","year":"2011","journal-title":"Canadian family physician Medecin de famille canadien"},{"key":"10.1016\/j.jogc.2023.05.012_bib25","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00228-011-1069-5","article-title":"Effects of codeine on pregnancy outcome: results from a large population-based cohort study","volume":"67","author":"Nezvalov\u00e1-Henriksen","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jogc.2023.05.012_bib26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s10995-014-1536-6","article-title":"Clinical correlates of prescription opioid analgesic use in pregnancy","volume":"19","author":"Smith","year":"2015","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.jogc.2023.05.012_bib27","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jogc.2018.04.018","article-title":"No. 364-Antenatal Corticosteroid Therapy for Improving Neonatal Outcomes","volume":"40","author":"Skoll","year":"2018","journal-title":"Journal of Obstetrics and Gynaecology Canada"},{"key":"10.1016\/j.jogc.2023.05.012_bib28","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/AOG.0000000000002237","article-title":"Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib29","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1360-0443.2010.02982.x","article-title":"First-trimester fetal heart rate in mothers with opioid addiction","volume":"105","author":"Schmid","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.jogc.2023.05.012_bib30","doi-asserted-by":"crossref","first-page":"529 e1","DOI":"10.1016\/j.ajog.2017.01.040","article-title":"Maternal buprenorphine treatment and fetal neurobehavioral development","volume":"216","author":"Jansson","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2011.10.003","article-title":"Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: a comparison of fetal neurobehaviors and infant outcomes","volume":"122","author":"Jansson","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jogc.2023.05.012_bib32","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ajog.2005.02.075","article-title":"Fetal response to maternal methadone administration","volume":"193","author":"Jansson","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jsgi.2005.11.001","article-title":"Effect of chronic maternal methadone therapy on intrapartum fetal heart rate patterns","volume":"13","author":"Ramirez-Cacho","year":"2006","journal-title":"J\u00a0Soc Gynecol Investig"},{"key":"10.1016\/j.jogc.2023.05.012_bib34","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/00003081-199809000-00019","article-title":"Antepartum testing","volume":"41","author":"Miller","year":"1998","journal-title":"Clin Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.jogc.2023.05.012_bib35","doi-asserted-by":"crossref","first-page":"36S-S","DOI":"10.1097\/01.AOG.0000532962.54525.c2","article-title":"Antepartum Monitoring of the Fetus Chronically Exposed to Opioids: What To Expect and Why Do We Intervene? [22C","volume":"131","author":"Brar","year":"2018","journal-title":"Obstetrics and gynecology (New York 1953)"},{"key":"10.1016\/j.jogc.2023.05.012_bib36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ogc.2014.02.010","article-title":"Neonatal opioid withdrawal syndrome","volume":"41","author":"Sutter","year":"2014","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.jogc.2023.05.012_bib37","series-title":"Neonatal Abstinence Syndrome","author":"Anbalagan","year":"2022"},{"key":"10.1016\/j.jogc.2023.05.012_bib38","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.6428","article-title":"Maternal and Child Health After Prenatal Opioid Exposure","volume":"2","author":"Brogly","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jogc.2023.05.012_bib39","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.acap.2019.11.005","article-title":"Neurodevelopmental Outcomes of Children Born to Opioid-Dependent Mothers: A Systematic Review and Meta-Analysis","volume":"20","author":"Lee","year":"2020","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.jogc.2023.05.012_bib40","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.28588","article-title":"Characteristics of\u00a0Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns","volume":"5","author":"Esposito","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jogc.2023.05.012_bib41","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ajog.2019.07.022","article-title":"Opioids affect the fetal brain: reframing the detoxification debate","volume":"221","author":"Caritis","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib42","article-title":"Factors in children with a history of neonatal abstinence syndrome at 10 years of age: Evidence from the maternal lifestyle study","volume":"27","author":"Miller","year":"2022","journal-title":"J\u00a0Spec Pediatr Nurs"},{"key":"10.1016\/j.jogc.2023.05.012_bib43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/ajad.12483","article-title":"Association of maternal and infant variants in PNOC and COMT genes with neonatal abstinence syndrome severity","volume":"26","author":"Wachman","year":"2017","journal-title":"Am J Addict"},{"key":"10.1016\/j.jogc.2023.05.012_bib44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/pch\/pxx199","article-title":"Managing infants born to mothers who have used opioids during pregnancy","volume":"23","author":"Lacaze-Masmonteil","year":"2018","journal-title":"Paediatrics & Child Health"},{"key":"10.1016\/j.jogc.2023.05.012_bib45","doi-asserted-by":"crossref","first-page":"e1163","DOI":"10.1542\/peds.2005-1561","article-title":"Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers","volume":"117","author":"Abdel-Latif","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jogc.2023.05.012_bib46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/bfm.2009.0079","article-title":"Breastfeeding rates among mothers of infants with neonatal abstinence syndrome","volume":"5","author":"Wachman","year":"2010","journal-title":"Breastfeed Med"},{"key":"10.1016\/j.jogc.2023.05.012_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6985164","article-title":"Chronic Pain Prevalence and Exposures during Pregnancy","volume":"2019","author":"Ray-Griffith","year":"2019","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.jogc.2023.05.012_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2023.05.012_bib49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2147\/IJWH.S151845","article-title":"Chronic pain during pregnancy: a review of the literature","volume":"10","author":"Ray-Griffith","year":"2018","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.jogc.2023.05.012_bib50","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.clp.2019.08.013","article-title":"Pain, Opioids, and Pregnancy: Historical Context and Medical Management","volume":"46","author":"Martin","year":"2019","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.jogc.2023.05.012_bib51","first-page":"25","article-title":"Treating pain during pregnancy","volume":"56","author":"Babb","year":"2010","journal-title":"Canadian family physician Medecin de famille canadien"},{"key":"10.1016\/j.jogc.2023.05.012_bib52","first-page":"113","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.jogc.2023.05.012_bib53","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2174\/138920012800166607","article-title":"Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn","volume":"13","author":"Antonucci","year":"2012","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.jogc.2023.05.012_bib54","first-page":"CR255","article-title":"A\u00a0preliminary study of 24-hour post-cesarean patient controlled analgesia: postoperative pain reports and morphine requests\/utilization are greater in abstaining smokers than non-smokers","volume":"11","author":"Marco","year":"2005","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jogc.2023.05.012_bib55","first-page":"CD010078","article-title":"Pharmacological interventions for promoting smoking cessation during pregnancy","author":"Coleman","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2023.05.012_bib56","first-page":"CD001837","article-title":"Interventions for smoking cessation in hospitalised patients","volume":"5","author":"Rigotti","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2023.05.012_bib57","first-page":"CD007238","article-title":"Early versus late initiation of epidural analgesia for labour","author":"Sng","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2023.05.012_bib58","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/0310057X0403200406","article-title":"Challenges that opioid-dependent women present to the obstetric anaesthetist","volume":"32","author":"Cassidy","year":"2004","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.jogc.2023.05.012_bib59","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1177\/0310057X0703500605","article-title":"Drug abuse and dependency during pregnancy: anaesthetic issues","volume":"35","author":"Ludlow","year":"2007","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.jogc.2023.05.012_bib60","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.drugalcdep.2005.10.001","article-title":"Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution","volume":"82","author":"Lejeune","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jogc.2023.05.012_bib61","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1055\/a-1788-5894","article-title":"Temporal Trends in Postpartum Opioid Prescribing, Opioid Use, and Pain Control Satisfaction","volume":"39","author":"Badreldin","year":"2022","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jogc.2023.05.012_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109331","article-title":"Trends, patterns, and maternal characteristics of opioid prescribing during pregnancy in a large population-based cohort study","volume":"233","author":"Nechuta","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jogc.2023.05.012_bib63","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e318256496e","article-title":"ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy","volume":"119","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib64","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/jmwh.13019","article-title":"Maternity Care for Pregnant Women with Opioid Use Disorder: A Review","volume":"64","author":"Rizk","year":"2019","journal-title":"J\u00a0Midwifery Womens Health"},{"key":"10.1016\/j.jogc.2023.05.012_bib65","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jogc.2017.07.017","article-title":"Screening and Management of Substance Use in Pregnancy: A Review","volume":"39","author":"Cook","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2023.05.012_bib66","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/14659891003721133","article-title":"Self-report of illicit substance use versus urine toxicology results from at-risk pregnant women","volume":"16","author":"Yonkers","year":"2011","journal-title":"J\u00a0Subst Use"},{"key":"10.1016\/j.jogc.2023.05.012_bib67","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.wombi.2021.12.009","article-title":"Barriers to women's disclosure of and treatment for substance use during pregnancy: A qualitative study","volume":"35","author":"Oni","year":"2022","journal-title":"Women Birth"},{"key":"10.1016\/j.jogc.2023.05.012_bib68","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jogc.2017.04.028","article-title":"349-Substance Use in Pregnancy","volume":"39","author":"Ordean","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2023.05.012_bib69","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/add.14651","article-title":"Accuracy of five self-report screening instruments for substance use in pregnancy","volume":"114","author":"Ondersma","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.jogc.2023.05.012_bib70","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/AOG.0b013e3181ed8290","article-title":"Screening for prenatal substance use: development of the Substance Use Risk Profile-Pregnancy scale","volume":"116","author":"Yonkers","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1874473711104010057","article-title":"A\u00a0review of the psychometric properties of the CRAFFT instrument: 1999-2010","volume":"4","author":"Dhalla","year":"2011","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1016\/j.jogc.2023.05.012_bib72","series-title":"Resource Guide: Screening for Drug Use in General Medical Settings","year":"2012"},{"key":"10.1016\/j.jogc.2023.05.012_bib73","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/sj.jp.7211823","article-title":"Validation of the 4P's Plus screen for substance use in pregnancy validation of the 4P's Plus","volume":"27","author":"Chasnoff","year":"2007","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.jogc.2023.05.012_bib74","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.genhosppsych.2007.01.011","article-title":"Implementing a clinical and research registry in obstetrics: overcoming the barriers","volume":"29","author":"Bentley","year":"2007","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.jogc.2023.05.012_bib75","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0002-9378(72)90777-6","article-title":"Heroin addiction during pregnancy","volume":"113","author":"Statzer","year":"1972","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib76","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/dar.13421","article-title":"A\u00a0qualitative meta-synthesis of pregnant women's experiences of accessing and receiving treatment for opioid use disorder","volume":"41","author":"Tsuda-McCaie","year":"2022","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.jogc.2023.05.012_bib77","first-page":"CD006037","article-title":"Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions","author":"Terplan","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2023.05.012_bib78","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40429-020-00296-x","article-title":"Advancing preventive interventions for pregnant women who are opioid using via the integration of addiction and mental health research","volume":"7","author":"Seghete","year":"2020","journal-title":"Curr Addict Rep"},{"key":"10.1016\/j.jogc.2023.05.012_bib79","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ajog.2014.04.005","article-title":"Brief interventions for illicit drug use among peripartum women","volume":"211","author":"Farr","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib80","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: a national clinical practice guideline","volume":"190","author":"Bruneau","year":"2018","journal-title":"CMAJ"},{"key":"10.1016\/j.jogc.2023.05.012_bib81","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ajog.2016.10.003","article-title":"Opioid dependence and pregnancy: minimizing stress on the fetal brain","volume":"216","author":"McCarthy","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib82","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/AOG.0000000000002562","article-title":"Opioid Detoxification During\u00a0Pregnancy: A Systematic Review","volume":"131","author":"Terplan","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib83","doi-asserted-by":"crossref","first-page":"10481","DOI":"10.1080\/14767058.2022.2130238","article-title":"Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine\/naloxone","volume":"35","author":"Petrich","year":"2022","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jogc.2023.05.012_bib84","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1503\/cmaj.100187","article-title":"Opioids for chronic noncancer pain: a new Canadian practice guideline","volume":"182","author":"Furlan","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.jogc.2023.05.012_bib85","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1479-828X.2001.tb01322.x","article-title":"Obstetric and neonatal outcomes associated with maternal naltrexone exposure","volume":"41","author":"Hulse","year":"2001","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib86","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.clinthera.2019.07.003","article-title":"Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects","volume":"41","author":"Wachman","year":"2019","journal-title":"Clinical therapeutics"},{"key":"10.1016\/j.jogc.2023.05.012_bib87","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1360-0443.2012.03811.x","article-title":"Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research","volume":"108","author":"Jones","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.jogc.2023.05.012_bib88","series-title":"Naltrexone. Drugs and Lactation Database (LactMed)","year":"2006"},{"key":"10.1016\/j.jogc.2023.05.012_bib89","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/add.13462","article-title":"Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child","volume":"111","author":"Zedler","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.jogc.2023.05.012_bib90","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/aogs.14497","article-title":"Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder","volume":"102","author":"Kanervo","year":"2023","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogc.2023.05.012_bib91","first-page":"CD006318","article-title":"Maintenance agonist treatments for opiate-dependent pregnant women","author":"Minozzi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"10.1016\/j.jogc.2023.05.012_bib92","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1360-0443.2012.04035.x","article-title":"Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.jogc.2023.05.012_bib93","first-page":"241","article-title":"The Use of Serum Methadone\/Metabolite Ratios to Monitor Changing Perinatal Pharmacokinetics","volume":"12","author":"McCarthy","year":"2018","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.jogc.2023.05.012_bib94","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/14767050802452291","article-title":"Maternal methadone dosing schedule and fetal neurobehaviour","volume":"22","author":"Jansson","year":"2009","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"Suppl 1","key":"10.1016\/j.jogc.2023.05.012_bib95","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1360-0443.2012.04037.x","article-title":"Fetal assessment before and after dosing with buprenorphine or methadone","volume":"107","author":"Salisbury","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.jogc.2023.05.012_bib96","doi-asserted-by":"crossref","first-page":"e1013","DOI":"10.4088\/JCP.16m11318","article-title":"Corrected QT Interval and Methadone Dose and Concentrations in Pregnant and Postpartum Women","volume":"78","author":"Bogen","year":"2017","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jogc.2023.05.012_bib97","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jogc.2023.05.012_bib98","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2023.05.012_bib99","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1080\/10826084.2022.2083174","article-title":"Buprenorphine Compared with Methadone in Pregnancy: A Systematic Review and Meta-Analysis","volume":"57","author":"Kinsella","year":"2022","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.jogc.2023.05.012_bib100","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa2203318","article-title":"Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy","volume":"387","author":"Suarez","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2023.05.012_bib101","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of drugs in pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jogc.2023.05.012_bib102","doi-asserted-by":"crossref","first-page":"459 e1","DOI":"10.1016\/j.ajog.2017.06.029","article-title":"An evidence-based recommendation to increase the dosing frequency of buprenorphine during pregnancy","volume":"217","author":"Caritis","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib103","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00482-005-0445-4","article-title":"[Transdermal buprenorphine during pregnancy]","volume":"20","author":"Ebner","year":"2006","journal-title":"Schmerz"},{"key":"10.1016\/j.jogc.2023.05.012_bib106","series-title":"Buprenorphine Formulations in Pregnancy: Safety & Efficacy Considerations for Canadians","year":"2021"},{"key":"10.1016\/j.jogc.2023.05.012_bib107","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0278-6915(02)00115-1","article-title":"Developmental toxicity of N-methyl-2-pyrrolidone administered orally to rats","volume":"40","author":"Saillenfait","year":"2002","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jogc.2023.05.012_bib108","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3127676","article-title":"Subcutaneous Extended-Release Buprenorphine Use in Pregnancy","volume":"2020","author":"Towers","year":"2020","journal-title":"Case Reports in Obstetrics and Gynecology"},{"key":"10.1016\/j.jogc.2023.05.012_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2020.106014","article-title":"Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations","volume":"93","author":"Winhusen","year":"2020","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jogc.2023.05.012_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2020.100179","article-title":"Buprenorphine-naloxone use in pregnancy: a systematic review and metaanalysis","volume":"2","author":"Link","year":"2020","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.jogc.2023.05.012_bib111","author":"Limited"},{"key":"10.1016\/j.jogc.2023.05.012_bib112","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s40501-020-00221-z","article-title":"Buprenorphine Dosing for the Treatment of Opioid Use Disorder Through Pregnancy and Postpartum","volume":"7","author":"Martin","year":"2020","journal-title":"Current Treatment Options in Psychiatry"},{"key":"10.1016\/j.jogc.2023.05.012_bib114","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1360-0443.1999.9422317.x","article-title":"Comparison of methadone and slow-release morphine maintenance in pregnant addicts","volume":"94","author":"Fischer","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.jogc.2023.05.012_bib115","first-page":"47","article-title":"Case report: Pregnancy and birth under heroin-assisted treatment (HAT)","volume":"16","author":"Groh","year":"2014","journal-title":"Heroin Addict Relat Clin Probl"},{"key":"10.1016\/j.jogc.2023.05.012_bib116","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000113726","article-title":"Pregnancy and birth under maintenance treatment with diamorphine (heroin): a case report","volume":"14","author":"Hartwig","year":"2008","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.jogc.2023.05.012_bib117","first-page":"435","article-title":"Use of Injectable Opioid Agonist Therapy in a In-Patient Setting for a Pregnant Patient With Opioid Use Disorder: A Case Report","volume":"15","author":"Griffiths","year":"2021","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.jogc.2023.05.012_bib119","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/08897077.2015.1118720","article-title":"Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: A retrospective cohort study","volume":"37","author":"Krans","year":"2016","journal-title":"Subst Abus"},{"key":"10.1016\/j.jogc.2023.05.012_bib120","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s10995-017-2316-x","article-title":"Hepatitis C Cascade of Care Among Pregnant Women on Opioid Agonist Pharmacotherapy Attending a Comprehensive Prenatal Program","volume":"21","author":"Page","year":"2017","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.jogc.2023.05.012_bib121","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jogc.2017.04.007","article-title":"No. 96-The Reproductive Care of Women Living With Hepatitis C Infection","volume":"39","author":"Boucher","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2023.05.012_bib122","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jogc.2020.09.007","article-title":"Guideline No. 409: Intrauterine Fetal Diagnostic Testing in Women with Chronic Viral Infections","volume":"42","author":"Wilson","year":"2020","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2023.05.012_bib123","doi-asserted-by":"crossref","first-page":"E650","DOI":"10.1503\/cmaj.181662","article-title":"Preventing vertical transmission of HCV in Canada","volume":"191","author":"Elwood","year":"2019","journal-title":"CMAJ"},{"key":"10.1016\/j.jogc.2023.05.012_bib124","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/cid\/ciy585","article-title":"Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection","volume":"67","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jogc.2023.05.012_bib125","first-page":"B8","article-title":"Electronic address pso, Dotters-Katz SK, Kuller JA, Hughes BL. Society for Maternal-Fetal Medicine Consult Series #56: Hepatitis C in pregnancy-updated guidelines: Replaces Consult Number 43, November 2017","volume":"225","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib126","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/GRF.0000000000000345","article-title":"Hepatitis C in Pregnancy in the Era of Direct-acting Antiviral Treatment: Potential Benefits of Universal Screening and Antepartum Therapy","volume":"61","author":"Bernstein","year":"2018","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib127","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jogc.2016.11.001","article-title":"No. 342-Hepatitis B and Pregnancy","volume":"39","author":"Castillo","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2023.05.012_bib128","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.1016\/j.vaccine.2018.08.074","article-title":"Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study","volume":"36","author":"Groom","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jogc.2023.05.012_bib129","author":"Government of Canada"},{"key":"10.1016\/j.jogc.2023.05.012_bib130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.14423\/SMJ.0000000000001105","article-title":"Opioid Use Among HIV-Positive Pregnant Women and the Risk for Maternal-Fetal Complications","volume":"113","author":"Nguyen","year":"2020","journal-title":"South Med J"},{"key":"10.1016\/j.jogc.2023.05.012_bib131","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jogc.2017.06.033","article-title":"No. 354-Canadian HIV Pregnancy Planning Guidelines","volume":"40","author":"Loutfy","year":"2018","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2023.05.012_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2019.105779","article-title":"Sexual risk behaviors and STDs among persons who inject drugs: A national study","volume":"126","author":"Brookmeyer","year":"2019","journal-title":"Prev Med"},{"key":"10.1016\/j.jogc.2023.05.012_bib134","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132776","article-title":"Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta-Analysis","volume":"10","author":"Lunny","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jogc.2023.05.012_bib135","series-title":"Screening for Gonorrhea and Chlamydia: Systematic Review to Update the US Preventive Services Task Force Recommendations","author":"Nelson","year":"2014"},{"key":"10.1016\/j.jogc.2023.05.012_bib136","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5758387","article-title":"Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature","volume":"2016","author":"Chan","year":"2016","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib137","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/AOG.0000000000002804","article-title":"Rectal Chlamydia trachomatis and Neisseria gonorrhoeae Infections Among Women Reporting Anal Intercourse","volume":"132","author":"Llata","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003351","article-title":"Estimated drug overdose deaths averted by North America's first medically-supervised safer injection facility","volume":"3","author":"Milloy","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jogc.2023.05.012_bib139","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","article-title":"The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence","volume":"106","author":"Turner","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.jogc.2023.05.012_bib140","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/AOG.0000000000002734","article-title":"Fatal and Nonfatal Overdose Among Pregnant and Postpartum Women in Massachusetts","volume":"132","author":"Schiff","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib141","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1186\/s12889-021-10497-2","article-title":"Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review","volume":"21","author":"Moustaqim-Barrette","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jogc.2023.05.012_bib142","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13669-016-0168-9","article-title":"Caring for Pregnant Women with Opioid Use Disorder in the USA: Expanding and Improving Treatment","volume":"5","author":"Saia","year":"2016","journal-title":"Current obstetrics and gynecology reports"},{"key":"10.1016\/j.jogc.2023.05.012_bib143","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1503\/cmaj.131723","article-title":"The management of opioid dependence during pregnancy in rural and remote settings","volume":"187","author":"Jumah","year":"2015","journal-title":"CMAJ : Canadian Medical Association journal\u00a0= journal de l'Association medicale canadienne"},{"key":"10.1016\/j.jogc.2023.05.012_bib144","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1093\/pch\/pxy091","article-title":"Differences in hospital length of stay between neonates exposed to buprenorphine versus methadone in utero: A retrospective chart review","volume":"24","author":"Fernandez","year":"2019","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.jogc.2023.05.012_bib145","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/08897077.2018.1488336","article-title":"Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states","volume":"40","author":"Patrick","year":"2019","journal-title":"Subst Abus"},{"key":"10.1016\/j.jogc.2023.05.012_bib146","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(13)60913-7","article-title":"Indigenous Canadians confront prescription opioid misuse","volume":"381","author":"Webster","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2023.05.012_bib147","doi-asserted-by":"crossref","first-page":"e616","DOI":"10.17269\/CJPH.108.5524","article-title":"Opioid use in pregnancy and parenting: An Indigenous-based, collaborative framework for Northwestern Ontario","volume":"108","author":"Jumah","year":"2018","journal-title":"Can J Public Health"},{"key":"10.1016\/j.jogc.2023.05.012_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107652","article-title":"Treatment for substance use disorders in pregnant women: Motivators and barriers","volume":"205","author":"Frazer","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jogc.2023.05.012_bib149","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/0193945919893372","article-title":"Health Care Encounters of Pregnant and Postpartum Women with Substance Use Disorders","volume":"42","author":"Renbarger","year":"2020","journal-title":"West J Nurs Res"},{"key":"10.1016\/j.jogc.2023.05.012_bib150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.semperi.2019.01.002","article-title":"Models of care for opioid dependent pregnant women","volume":"43","author":"Johnson","year":"2019","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jogc.2023.05.012_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2021.100489","article-title":"Integrated vs nonintegrated treatment for perinatal opioid use disorder: retrospective cohort study","volume":"4","author":"Goodman","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.jogc.2023.05.012_bib152","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsat.2018.04.008","article-title":"Integrated treatment programs for pregnant and parenting women with problematic substance use: Service descriptions and client perceptions of care","volume":"90","author":"Tarasoff","year":"2018","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.jogc.2023.05.012_bib153","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jogc.2020.10.021","article-title":"Prenatal Care Outcomes in Women with Substance Use Disorders: A Retrospective Cohort Study","volume":"43","author":"Lennox","year":"2021","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2023.05.012_bib154","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/1533256X.2016.1243122","article-title":"Women Attending High-Risk Substance Abuse Clinics Versus General Obstetrics Clinics","volume":"17","author":"Lewis","year":"2017","journal-title":"Journal of Social Work Practice in the Addictions"},{"key":"10.1016\/j.jogc.2023.05.012_bib155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12884-020-03109-1","article-title":"Multi-service prevention programs for pregnant and parenting women with substance use and multiple vulnerabilities: Program structure and clients\u2019 perspectives on wraparound programming","volume":"20","author":"Rutman","year":"2020","journal-title":"BMC Pregnancy and Childbirth"},{"key":"10.1016\/j.jogc.2023.05.012_bib156","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.jp.7210847","article-title":"Perinatal substance abuse intervention in obstetric clinics decreases adverse neonatal outcomes","volume":"23","author":"Armstrong","year":"2003","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.jogc.2023.05.012_bib157","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/AOG.0b013e31823d427d","article-title":"Early start: a cost-beneficial\u00a0perinatal substance abuse program","volume":"119","author":"Goler","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.012_bib158","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/09540261.2021.1908966","article-title":"Comprehensive and compassionate responses for opioid use disorder among pregnant and parenting women","volume":"33","author":"Hand","year":"2021","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.jogc.2023.05.012_bib159","first-page":"e462","article-title":"Integrated care for pregnant women on methadone maintenance treatment: Canadian primary care cohort study","volume":"59","author":"Ordean","year":"2013","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jogc.2023.05.012_bib160","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1176\/appi.ps.201300235","article-title":"Medication-assisted treatment with methadone: assessing the evidence","volume":"65","author":"Fullerton","year":"2014","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jogc.2023.05.012_bib161","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2009","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2023.05.012_bib162","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11904-010-0059-z","article-title":"Drug treatment as HIV prevention: expanding treatment options","volume":"7","author":"Metzger","year":"2010","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.jogc.2023.05.012_bib163","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1360-0443.2011.03700.x","article-title":"Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings","volume":"107","author":"Schwartz","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.jogc.2023.05.012_bib164","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.drugalcdep.2007.11.021","article-title":"A\u00a0randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification","volume":"94","author":"Gruber","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jogc.2023.05.012_bib165","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jogc.2023.05.012_bib166","article-title":"Product Monograph Iincluding Patient Medication Information: NBuTrans\u00ae 5, NBuTrans\u00ae 10, NBuTrans\u00ae 15, NBuTrans\u00ae 20, Buprenorphine Transdermal System, Patch, 5, 10, 15 and 20 mcg\/h, Transdermal, Purdue Pharma Standard","year":"2021","journal-title":"Opioid Analgesic"},{"key":"10.1016\/j.jogc.2023.05.012_bib167","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/03639045.2013.846365","article-title":"Pharmaceutical and pharmacokinetic characterization of a novel sublingual buprenorphine\/naloxone tablet formulation in healthy volunteers","volume":"41","author":"Fischer","year":"2015","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.jogc.2023.05.012_bib168","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/dar.12344","article-title":"Diversion and injection of buprenorphine\u2013naloxone film two years post-introduction in Australia","volume":"35","author":"Larance","year":"2016","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jogc.2023.05.012_bib169","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsat.2014.02.003","article-title":"Abuse and diversion of buprenorphine sublingual tablets and film","volume":"47","author":"Lavonas","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jogc.2023.05.012_bib170","unstructured":"Canadian Research Initiative in Substance Misuse. CRISM National Guideline for the Clinical Management of Opioid Use Disorder."},{"key":"10.1016\/j.jogc.2023.05.012_bib171","article-title":"Product Monograph including Patient Medication Information. NSUBLOCADETM Buprenorphine extended-release injection. Solution; 100 mg \/ 0.5 mL, 300 mg \/ 1.5 mL; Subcutaneous Injection","year":"2018","journal-title":"Partial Opioid Agonist"},{"key":"10.1016\/j.jogc.2023.05.012_bib172","series-title":"Buprenorphine Formulations in Pregnancy: Safety & Efficacy Considerations for Canadians","year":"2021"},{"key":"10.1016\/j.jogc.2023.05.012_bib173","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12954-020-00392-1","article-title":"Opioid agonist therapy uptake among people who inject drugs: the findings of two consecutive bio-behavioral surveillance surveys in Iran","volume":"17","author":"Nakhaeizadeh","year":"2020","journal-title":"Harm reduction journal"},{"key":"10.1016\/j.jogc.2023.05.012_bib174","article-title":"Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting","author":"Berk","year":"2021","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.jogc.2023.05.012_bib175","first-page":"Cd009879","article-title":"Slow-release oral morphine as maintenance therapy for opioid dependence","author":"Ferri","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2023.05.012_bib176","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jamapsychiatry.2016.0109","article-title":"Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial","volume":"73","author":"Oviedo-Joekes","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jogc.2023.05.012_bib177","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1192\/bjp.bp.114.149195","article-title":"Heroin on trial: Systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction","volume":"207","author":"Strang","year":"2015","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jogc.2023.05.012_bib178","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13011-021-00360-3","article-title":"\"They're not doing enough.\": women's experiences with opioids and naloxone in Toronto","volume":"16","author":"Macleod","year":"2021","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.jogc.2023.05.012_bib179","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.2146\/ajhp170759","article-title":"Development and implementation of procedures for outpatient naloxone prescribing at a large academic medical center","volume":"75","author":"Zschoche","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jogc.2023.05.012_bib180","first-page":"538","article-title":"Can naloxone prescription and overdose training for opioid users work in family practice? Perspectives of family physicians","volume":"61","author":"Leece","year":"2015","journal-title":"Can Fam Physician"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S170121632300381X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S170121632300381X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:44:12Z","timestamp":1761666252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S170121632300381X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":175,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S170121632300381X"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2023.05.012","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guideline No. 443b: Opioid Use Throughout Women\u2019s Lifespan: Opioid Use in Pregnancy and Breastfeeding","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2023.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102144"}}